maprotiline has been researched along with Exanthema in 1 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Exanthema: Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The first 2 days patients received a high initial dosage of 300 mg per day." | 2.64 | [Clinical double-blind study with two different dosages of maprotiline (150 and 225 mg per day) (author's transl)]. ( Angst, J; Gmuer, M; Hess, K; Hurwitz, E; Martens, H; Rothweiler, R; Steiner, A; Woggon, B, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Woggon, B | 1 |
| Angst, J | 1 |
| Gmuer, M | 1 |
| Hess, K | 1 |
| Hurwitz, E | 1 |
| Martens, H | 1 |
| Rothweiler, R | 1 |
| Steiner, A | 1 |
1 trial available for maprotiline and Exanthema
| Article | Year |
|---|---|
[Clinical double-blind study with two different dosages of maprotiline (150 and 225 mg per day) (author's transl)].
Topics: Adult; Anthracenes; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; Exanthem | 1976 |